Waters Corporation (WAT) has been at the center of multiple financial discussions, with a mixed bag of performance across the span of the third quarter. The company had commendable performance during Q3, recording
strong revenue and margin increases. Resultantly, the firm's stocks made notable gains on S&P 500, even beating estimates. Similarly, the results led to a raised price target by TD Cowen, touching $410. This positive market performance contributed towards WAT's stock hitting a 52-week high at $375. However, periods of
underperformance were also registered with the company's stock falling behind competitors on multiple occasions. On the innovation front, WAT continues to stride forth with the unveiling of a
cloud-based Lab Intelligence Software, aiming for annual cost savings of $600k. Q3 results also saw Waters Corp increase its manufacturing capacity with a new high-tech UK facility boosting its strategic expansion. Despite positive results, some investors chose to reduce their stakes with OVERSEA CHINESE BANKING Corp Ltd selling 13,526 shares and Boston Financial Management LLC also offloading some. To further enhance financial performance, the biotech firm heightens focus on lab-centric business intelligence and aims for confident audit-readiness.
WAT raised its earnings guidance for the fiscal year ending 2024.
Waters Corp WAT News Analytics from Thu, 28 Jun 2018 13:45:29 GMT to Fri, 15 Nov 2024 22:08:00 GMT -
Rating 1
- Innovation 7
- Information 8
- Rumor 1
